"We must not be left behind with new prostate cancer treatments."
PHEN president and founder Thomas A. Farrington talks about his prostate cancer journey and the importance of African American men participating in clinical trials.
Understanding the possible benefits for patients when participating in a clinical trial.
Clinical trials offer important and unique benefits to patients.
Dr. Jacques Carter Presents Clinical Trials 101 for Patients
Dr. Carter's brief video presentations provide basic information for patients to better understand clinical trials.
What Are Clinical Trials?
Information that all patients need to know when considering enrolling into a clinical trial.
EMBARK clinical trial summary
For patients with a rising PSA after being treated with surgery, radiation or both.
ENACT clinical trial summary
For patients considering active surveillance or currently undergoing active surveillance.
ARAMIS clinical trial summary
Patients should consider this trial if hormone therapy treatments no longer keep their PSA from rising but their
doctor has not detected any prostate cancer spread to other parts of the body.
ATLAS clinical trial summary
For patients diagnosed with high-risk, localized or locally advanced prostate cancer as determined by a high PSA and/or Gleason Score and cancer stage.
TITAN Clinical Trial Summary
The TITAN trial is for patients with prostate cancer that has spread to their bones but androgen deprivation (hormone) therapy is still effective in keeping the PSA low. This is called Metastatic Hormone-sensitive Prostate Cancer (mHSPC).
A listing of all the prostate cancer clinical trials listed on clinicaltrials.gov that are currently recruiting patients.